Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ULARH: Adrenalectomy vs Medical Treatment for Resistant Hypertension
NCT03535532Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2018
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in resistant hypertension (RH) (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Composite of end-point events at 3 years. Status: unknown.
02
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT03535532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535532.